GlassScriptPhysician profile
Jamie S Young
NPI 1265999007
$5,455.96
in general payments reported to CMS, 2019-2025
35 companies · $530 in 2025
The $530 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,200 · 2022: $1,209 · 2023: $1,859 · 2024: $658 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,007 · Education: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,007.03 |
| Education | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,383.87 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $573.24 | 2021-2024 | Ofev, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $550.32 | 2021-2025 | Bevespi Aerosphere, Evusheld, Breztri |
| Genzyme Corporation | $438.49 | 2022-2025 | |
| Abbott Laboratories | $333.09 | 2021-2024 | Freestyle Libre |
| Regeneron Healthcare Solutions, INC. | $332.79 | 2022-2025 | Dupixent |
| Abbvie INC. | $280.02 | 2021-2023 | |
| Csl Behring | $257.07 | 2023-2025 | Kcentra |
| Procept Biorobotics Corporation | $133.92 | 2023 | Aquabeam Robotic System |
| Grifols USA, LLC | $123.42 | 2022-2025 | Prolastin-C Liquid |
| Amgen INC. | $107.23 | 2022-2023 | Tezspire, Enbrel, Tavneos |
| United Therapeutics Corporation | $95.97 | 2024-2025 | Tyvaso, Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $80.96 | 2021-2023 | Glassia |
| Actelion Pharmaceuticals US, INC. | $79.91 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Insmed, INC. | $77.29 | 2022-2023 | Arikayce |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $72.88 | 2021-2024 | |
| Avadel Cns Pharmaceuticals, LLC | $62.86 | 2023-2024 | Lumryz |
| Jazz Pharmaceuticals INC. | $53.65 | 2023-2024 | |
| Mylan Specialty L.P. | $53.18 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $39.19 | 2021 | |
| Genentech USA, INC. | $38.54 | 2022 | |
| Novo Nordisk INC | $36.83 | 2021-2022 | |
| Inspire Medical Systems, INC. | $35.59 | 2025 | Inspire |
| Mallinckrodt Hospital Products INC. | $32.61 | 2024-2025 | Acthar |
| Lilly USA, LLC | $29.03 | 2021-2022 | |
| 3b Medical, INC. | $22.04 | 2025 | Luna |
| Horizon Therapeutics Plc | $20.79 | 2023 | Procysbi |
| Zoll Respicardia, INC. | $19.32 | 2023 | Remede System |
| Baxter Healthcare | $14.18 | 2024 | Hillrom - Monarch Airway Clearance System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.07 | 2021 | |
| Phathom Pharmaceuticals, INC. | $13.89 | 2024 | Voquezna |
| Amneal Pharmaceuticals LLC | $13.09 | 2021 | |
| Merck Sharp & Dohme LLC | $12.91 | 2023 | Belsomra |
| Bayer Healthcare Pharmaceuticals INC. | $12.35 | 2021 | |
| Advanced Respiratory, INC | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.